Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

NETs-associated H3.1-nucleosome measurements in plasma correlate with severity of Alzheimer’s Disease progression

Monday, October 16, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The poster presented by Candiracci et al. at the 33rd Alzheimer’s Europe Conference 2023 discusses the correlation between NETs-associated H3.1-nucleosome measurements in plasma and the severity of Alzheimer's Disease progression. This research highlights the potential of these measurements as a prognostic indicator for the disease. The findings contribute valuable insights into understanding Alzheimer's pathology.
Price reaction · baseline $13.2 (2023-10-13 close) · hit pre-market · 3 other VNRX headline(s) in the window, move may be shared
day 0 close
+0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • The study presents new insights into Alzheimer's Disease progression.
  • Measurements of H3.1-nucleosome in plasma could serve as a prognostic tool.
  • The findings were shared at a significant conference, enhancing visibility.

Full Press Release Details

Poster titled: “NETs-associated H3.1-nucleosome measurements in plasma correlate with severity of Alzheimer’s Disease progression.”
Presented at the 33rd Alzheimer’s Europe Conference 2023
Candiracci et al

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What does the study by Candiracci et al. focus on?

The study investigates the correlation between NETs-associated H3.1-nucleosome measurements in plasma and the severity of Alzheimer's Disease.

Where was the research presented?

The research was presented at the 33rd Alzheimer’s Europe Conference 2023.

What is the significance of H3.1-nucleosome measurements?

These measurements may serve as a prognostic tool for assessing Alzheimer's Disease progression.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Alzheimer's Disease H3.1-nucleosome NETs plasma measurements Candiracci
Last updated: Oct 16, 2023

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk